Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed as a minor UI cleanup.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on uveal melanoma and various types of antibodies. However, many related topics and specific location details have been removed.SummaryDifference4%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.